BerandaBICO • STO
add
BICO Group AB
Tutup sebelumnya
kr 39,78
Rentang hari
kr 39,34 - kr 41,48
Rentang tahun
kr 28,18 - kr 56,55
Kapitalisasi pasar
2,73Â M SEK
Volume Rata-Rata
277,22Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
STO
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
(SEK) | Des 2024info | Perubahan Y/Y |
---|---|---|
Pendapatan | 570,80Â jt | -12,56% |
Biaya operasional | 331,10Â jt | -33,37% |
Laba bersih | 346,80Â jt | 138,68% |
Margin laba bersih | 60,76 | 144,24% |
Penghasilan per saham | — | — |
EBITDA | 122,10Â jt | 41,81% |
Tarif pajak efektif | -1,02% | — |
Neraca
Total aset
Total liabilitas
(SEK) | Des 2024info | Perubahan Y/Y |
---|---|---|
Investasi tunai jangka pdk | 946,30Â jt | 9,91% |
Total aset | 5,48Â M | -30,57% |
Total liabilitas | 2,48Â M | -17,20% |
Total ekuitas | 3,01 M | — |
Saham yang beredar | 70,57 jt | — |
Harga terhadap nilai buku | 0,94 | — |
Tingkat pengembalian aset | -0,14% | — |
Tingkat pengembalian modal | -0,16% | — |
Arus Kas
Perubahan kas bersih
(SEK) | Des 2024info | Perubahan Y/Y |
---|---|---|
Laba bersih | 346,80Â jt | 138,68% |
Kas dari operasi | 181,60Â jt | 12,10% |
Kas dari investasi | 221,40Â jt | 14,36% |
Kas dari pembiayaan | -138,20Â jt | -183,20% |
Perubahan kas bersih | 264,00Â jt | -11,71% |
Arus kas bebas | 383,46Â jt | 8,41% |
Tentang
Bico Group is a bioconvergence startup that designs and supplies technologies and services to enhance biology research. It focuses on commercializing technologies for life science research as well as bioprinting, and its products often combine capabilities in artificial intelligence, robotics, multiomics, and diagnostics.
Bico Group began by producing bio-inks and bioprinters for culturing different cell types to enable applications like patient-derived implants. Bico Group was the first company to provide a standardized bio-ink product for sale over the internet.
The company has ongoing collaborations with organizations including AstraZeneca, MedImmune, MIT and Takara Bio, and its bioprinters are used for research at Harvard University, Merck, Novartis, the U.S. Army, Toyota, Johnson & Johnson and more. Wikipedia
Didirikan
27 Jan 2016
Situs
Karyawan
726